Alcami enhances analytical services in Edison, NJ

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Ca-ssis)
(Image: iStock/Ca-ssis)
The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

The CDMO offers comprehensive chemistry, environmental, and microbial capabilities at the facilities, in addition to multi-compendial testing and customized analysis.

According to the company, the Edison site is capable of meeting FDA requirements for Antibiotic Analysis both using USP < 81 > and can perform bridging analysis to an alternative method per USP < 1223.1 >. 

Additionally, Alcami has added​ 2,000 cubic feet of stability chamber space across its network, new control systems for all chambers, and a REES environmental monitoring system.

The company is also working to adopt Lean principles at its laboratories, a process which is said will be completed in 2017.

Alcami did not respond to a request for comment.

Related news

Show more

Related products

show more

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us

Products

View more

Webinars